In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DJO Global Inc.

Division of Colfax Corp.
www.djoglobal.com

Latest From DJO Global Inc.

Market Intel: Innovation Drives Growth, Draws Younger Patients In Joint Replacement Implants Market

The worldwide joint-replacement implants market is expected to hit $20bn by 2022, according to a new report from Meddevicetracker. The growth is driven by the rising number of elderly patients, whose natural joints have been damaged by arthritis, and the rising prevalence of chronic diseases, such as obesity and diabetes, and sport-related injuries. But a look at the market and the three largest segments  shoulder, knee and hip replacements  show that new technological advancements and improved surgical techniques are increasingly making joint replacement surgeries an option for younger people as well. Here's an overview and key insights from two orthopedic surgeons on the current market and key growth drivers and limiters.

Orthopedics Surgical Procedures

Avanos/Halyard Tops Recent Medtech CEO-To-Worker Pay Ratio Disclosures

While most device companies filing 2017 annual reports in the first half of 2018 showed CEO-to-worker pay ratios averaging 219:1, Halyard Health (recently renamed Avanos Medical) CEO Joseph F. Woody was compensated 1,250 times what the company’s median employee earned, according to recent disclosures. Medtech Insight also examined CEO-to-worker pay ratios at Align Technologies, Abbott Laboratories, Danaher and Bio-Rad Laboratories, among other firms.

Leadership Companies

$7.6m Settlement In TENS False-Claims Case

DJO Global is paying $7.62m to resolve allegations that former subsidiary Empi filed false claims to Tricare for electrodes used with TENS units.

Medical Device Orthopedics

Execs On The Move, April 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Leadership
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register